home > 

our team

our team


Dr David Nugent - Director

Dr David Nugent - Director

David founded Elucidare in 2003 after a highly successful career as an equities analyst in the London Stock Market. He graduated from Glasgow University in 1992 with a double-first class honours degree in Physics and Electronic Engineering, and a PhD in Engineering from Cambridge University in 1995. His work on ultrafast telecommunications lasers was funded by a Research Fellowship from British Telecom Research Laboratories.

After three years at Arthur D Little, the international management consulting firm, he moved into investment banking at Rabobank International where he founded the Technology equity research team. In 1999 he moved to APAX Securities where he built one of the most successful technology research teams in London. In the Reuters Surveys, he was the highest ranked analyst in both the Telecommunications Services and IT Hardware sectors simultaneously.


Jerel Whittingham - Associate, Technology Ventures

Jerel Whittingham - Associate

Jerel has extensive technology commercialisation experience in investor, operational or strategy roles with companies including Incuvest LLC, Generics Group PLC, Durlacher PLC, INMARSAT plc and with a number of venture start-ups. Currently he combines NED and operational roles in technology growth companies, including ROADMap Systems, an Elucidare portfolio company where he is CEO, and Aipolas ltd. Jerel's NED roles include Kromek, Ltd., where he chairs the compensation committee. Mr Whittingham has worked on several AIM IPOs and on commercialisation projects at a number of universities and leading European companies in diverse areas including media technologies, biosensors, diagnostics, aerospace, materials science, and medical imaging.

His commitment to company building in the tech sector builds on earlier career experience in R&D and then strategy development roles. He is a graduate of UCL, Cranfield, and Brussels Universities. Mr Whittingham is former Managing Director of Amphion Innovations plc during which time he also served as CEO and later Executive chairman of Myconostica ltd., a medical Diagnostics company.


Dr Claire Baker - Director

Dr David Nugent - Director

Claire graduated from Cambridge University with a Natural Science degree in 1996 and a PhD in Clinical Biochemistry in 2000. Her PhD was funded by the British Diabetic Association and investigated the role of fatty acids on glucose disposal. After working as a sub-editor at Cambridge University Press, Claire became a Clinical Researcher at Papworth Hospital, the largest specialist cardiothoracic hospital in the UK.